TG Therapeutics (NKB2) Revenue

3 Followers

TG Therapeutics Revenue

TG Therapeutics had a revenue of 240.34M in the quarter ending Jun 30, 2026, with 17.28%. This bring the company's revenue in the last twelve months to 799.54M, Decreased 14.16%. In the fiscal year ending Dec 31, 2025, TG Therapeutics had annual revenue of 616.29M with 87.32% growth.

Revenue (ttm)

799.54M

Revenue Growth

64.38%

P/S Ratio

12.21

Revenue/Employee

€1,544,579

Employees

399

Market Cap

€7.53B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	616.29M	287.28M	+87.32%
Dec 31, 2024	329.00M	95.34M	+40.80%
Dec 31, 2023	233.66M	230.88M	+8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	+4,300.66%
Dec 31, 2020	152.00K	0.00	―
Dec 31, 2019	152.00K	0.00	―
Dec 31, 2018	152.00K	-381.00	-0.25%
Dec 31, 2017	152.38K	―	―